Tue, 24 July 2012
A Placebo- and Midazolam-Controlled, Phase I, Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam: Part I. Safety, Efficacy, and Basic Pharmacokinetics and Part II: Population Pharmacokinetic and Pharmacodynamic Modeling and Simulation |